Melocox (Meloxicam)

Meloxicam works by preferentially inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the production of prostaglandins—chemical mediators that cause inflammation, pain, and fever. By sparing COX‑1 activity, it aims to maintain normal gastric protection while providing anti‑inflammatory and analgesic effects.

The exact dose of Melocox is individualized by the prescribing clinician based on the patient’s specific condition, severity of symptoms, renal and hepatic function, and any concomitant medications. Dosage adjustments are made according to clinical response and safety monitoring, not by a fixed over‑the‑counter regimen.

Safety data for meloxicam in pregnancy and lactation are limited. It is generally avoided during the first trimester and throughout pregnancy unless the potential benefit outweighs the risk. Breastfeeding mothers should also use caution, as the drug can be excreted in milk; a healthcare professional should assess the risk‑benefit ratio.

To request Melocox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Melocox (meloxicam) is a longer‑acting NSAID with greater selectivity for COX‑2, which may offer a lower risk of gastrointestinal irritation compared with non‑selective agents like ibuprofen. However, the overall cardiovascular and renal safety profile remains similar, and individual response can vary, so clinicians choose the agent based on patient‑specific factors.

Melocox should be stored at room temperature, typically below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Melocox is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with meals may reduce occasional stomach upset. Patients should follow the prescriber’s instructions regarding timing and any dose‑spacing requirements.

The most serious adverse events linked to meloxicam include gastrointestinal ulceration or bleeding, severe skin reactions such as Stevens‑Johnson syndrome, renal impairment that can progress to failure, and elevated liver enzymes indicating possible hepatotoxicity. Prompt medical attention is required if any of these symptoms develop.

Melocox is contraindicated in patients with a known hypersensitivity to meloxicam or other NSAIDs, those with active peptic ulcer disease, severe heart failure, or significant renal or hepatic impairment. It should also be avoided in individuals who have experienced serious cardiovascular events while using other COX‑2 inhibitors.